Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-26

Clinical Trial Update: Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 pilot randomized controlled trial evaluating postpartum heparin for prevention of venous thromboembolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED